Seroprevalence, risk associations, and cost analysis of screening for viral infections among patients of cataract surgery

Rewri, Parveen; Sharma, Madhavi; Vats, D P; Singhal, Aparna

doi:10.4103/ijo.ijo_726_17

Cited by 14 publications

(4 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the results of our study contributed to the detection of patients with infectious diseases at a much lower cost than the previous study [ 19 ], hepatitis screening was considered to be cost-effective for patients undergoing oral and maxillofacial surgery in Japan. On the other hand, HIV screening cost a lot when compared to a previous study [ 20 ]. An Indian study examining HIV screening and costs indicated it was $418.9 (screening patients = 4529 * $ 0.37 test costs/number of positive patients = 4) [ 20 ].…”

Section: Discussionmentioning

confidence: 93%

“…On the other hand, HIV screening cost a lot when compared to a previous study [ 20 ]. An Indian study examining HIV screening and costs indicated it was $418.9 (screening patients = 4529 * $ 0.37 test costs/number of positive patients = 4) [ 20 ]. Although it is not possible to make a simple comparison because the cost of testing and the number of people living with HIV varies from country to country, the cost-effectiveness of the universal screening test for HIV does not seem to be very good in Japan.…”

Section: Discussionmentioning

confidence: 93%

See 1 more Smart Citation

The Effectiveness of Pre-Operative Screening Tests in Determining Viral Infections in Patients Undergoing Oral and Maxillofacial Surgery

Sukegawa

Hasegawa

et al. 2022

Healthcare

View full text Add to dashboard Cite

We analyzed the rate of patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) infection diagnosed by pre-operative screening and estimated its cost. We retrospectively analyzed patients who underwent elective surgery at our maxillofacial surgery department between April 2014 and March 2022. We compared the number of patients with each infection identified by pre-operative screening and a pre-operative questionnaire. We also compared the prevalence of infections with varying age, sex, and oral diseases, and calculated the cost of screening per positive result. The prevalence of HBV, HCV, and HIV was 0.39% (62/15,842), 0.76% (153/15,839), and 0.07% (10/12,745), respectively. The self-reported rates were as follows: HBV, 63.4% (26/41); HCV, 50.4% (62/123); HIV, 87.5% (7/8). Differences in sex were statistically significant for all infectious diseases; age significantly affected HBV and HCV rates. There was no association between the odds ratio of oral disease and viral infections. The cost per positive result was $1873.8, $905.8, and $11,895.3 for HBV, HCV, and HIV, respectively. Although self-assessment using questionnaires is partially effective, it has inadequate screening accuracy. Formulating an auxiliary diagnosis of infectious diseases with oral diseases was challenging. The cost determined was useful for hepatitis, but not HIV.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Discussionmentioning

confidence: 93%

The Effectiveness of Pre-Operative Screening Tests in Determining Viral Infections in Patients Undergoing Oral and Maxillofacial Surgery

Sukegawa

Hasegawa

et al. 2022

Healthcare

View full text Add to dashboard Cite

show abstract

“…Hepatitis B, Hepatitis C, and human immunodeficiency virus 1 and 2 are not uncommon in eye care facilities, and prevalence can be as high as 6%. [ 3 , 4 ] As an institutional policy, we are routinely performing these tests for the following reasons.…”

Section: Screening For Viral Markersmentioning

confidence: 99%

“…[ 5 ] A significant proportion of patients testing seropositive for the above viral infections are asymptomatic carriers and are not aware of the condition. [ 3 , 4 ] …”

Section: Screening For Viral Markersmentioning

confidence: 99%